SCHEMBL6175149

SCHEMBL6175149

CC1(Cc2ccncc2NC(=O)c2cccc(Cl)c2)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.42
HSD17B13 Q7Z5P4 1/20 0.41
ABL1 P00519 9/20 0.40
LIPE Q05469 1/20 0.40
CYP3A4 P08684 1/20 0.39
GAA P10253 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
GSK3A P49840 1/20 0.37
GSK3B P49841 1/20 0.37
TRPV1 Q8NER1 2/20 0.37
BRAF P15056 1/20 0.37
GRM5 P41594 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173115 0.88 IGF1R (0.39) ALDH1A1HSD17B13BRAFMEN1KMT2A
SCHEMBL6172432 0.87 ALDH1A1 (0.38) ALDH1A1HSD17B13CYP3A4GAACYP2C9
SCHEMBL6277096 0.87 CYP3A4 (0.43) ALDH1A1HSD17B13ABL1CYP3A4GAA
SCHEMBL6174981 0.87 CYP3A4 (0.51) ALDH1A1ABL1CYP3A4GAACYP2C9
SCHEMBL6177279 0.86 TDP1 (0.42) ALDH1A1HSD17B13LIPECYP3A4GAA
SCHEMBL6171757 0.85 CYP3A4 (0.41) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6176657 0.84 CYP3A4 (0.40) ALDH1A1HSD17B13CYP3A4GAACYP2C9
SCHEMBL6171113 0.84 P2RY1 (0.43) CYP2C9
SCHEMBL2942596 0.84 LIPE (0.41) HSD17B13ABL1LIPEGSK3AGSK3B
SCHEMBL6174447 0.83 ALDH1A1 (0.44) ALDH1A1HSD17B13CYP3A4GAACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed